Ag-clopidogrel : May Contain Overweight Or Underweight Tablets
AG-Clopidogrel Recall Summary AG-Clopidogrel tablets distributed across Canada are being recalled because some tablets may weigh more or less than they should, which could affect the amount of active ingredient in each tablet. This is a Class I recall, meaning there is a serious potential health risk. The recall affects clopidogrel products distributed nationwide in Canada.
- Product
- AG-Clopidogrel
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2024-09-06
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/348ede1d-4c6e-4040-a686-f1dfbc53c22c